Objective To evaluate the clinical therapeutic efficacy of daidzeintablets on climacteric syndrome and osteoporosis.
目的探讨黄豆苷元片对更年期症状及骨质疏松症的临床治疗效果。
2
Conclusion: High dose of daidzeintablets may inhibit the activity of CYP3A in vivo, which needs the awareness of physicians because of the potential drug interaction.